IP Library Granted Patent US 12,343,514
Granted Patent B2
US 12,343,514 · App. 19/028,358 · Granted Jul 1, 2025

Drug delivery device with feedback mechanism

Inventors: Thomas Mark Kemp (Ashwell Herford, GB); Hugo Revellat (Royston, GB)
Assignee: Sanofi-Aventis Deutschland GMBH
A61M5/3157A61M5/2033A61M5/3245A61M2005/208A61M2005/3247A61M2005/3267A61M2205/581A61M2205/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,343,514
App. No.
19/028,358
Granted
Jul 1, 2025
Kind
B2
Abstract

A drug delivery device includes a case adapted to hold a medicament container, a plunger disposed within the case and slidable from a proximal position into a distal position for delivering a medicament from the medicament container, at least one feedback mechanism that is in operative connection with the plunger. The feedback mechanism comprises a collar, a control spring biasing the collar in a distal direction, a needle shroud, operatively axially abutting the collar in a first coupled state and prevented from axially decoupling the collar by the plunger in its proximal position The plunger, when approaching the distal position during movement from the proximal position towards the distal position, is adapted to allow axial decoupling of the needle shroud from the collar, allowing for a limited axial movement of the collar relative to the needle shroud until the collar axially abuts the needle shroud in a second coupled state.

Claims (46)

1. An autoinjector comprising:

a case adapted to receive at least a portion of a medicament container;

a plunger movable relative to the case along a longitudinal axis of the autoinjector between an initial position and a drug delivery position for delivering a medicament from the medicament container;

an inner sleeve configured to engage a proximal end of the plunger when the plunger is in the initial position, the inner sleeve comprising a tubular body and a flexible arm movable relative to the tubular body, the flexible arm comprising a first end coupled to the tubular body and a second end spaced from the tubular body, wherein the flexible arm is movable between an inwardly deflected position and a relaxed position; and

an outer sleeve comprising a sleeve body having a first end, a second end, and an interior surface defining a cylindrical cavity, the sleeve body comprising an opening radially extending through the sleeve body and longitudinally extending between the first end and the second end, wherein the opening is sized to receive a portion of the flexible arm,

wherein the autoinjector is configured such that after the plunger moves into the drug delivery position, the inner sleeve moves axially relative to the outer sleeve and into the cylindrical cavity of the outer sleeve, allowing the flexible arm to engage the interior surface of the outer sleeve and deflecting the flexible arm inwardly, and

wherein the autoinjector is configured such that an audible signal or a tactile signal is generated from an impact event between the inner sleeve and the outer sleeve to indicate completion of dispensing of the medicament.

2. The autoinjector of claim 1 , wherein the flexible arm comprises a projection extending radially outward relative to the longitudinal axis.

3. The autoinjector of claim 2 , wherein the opening in the outer sleeve is sized to receive the projection of the flexible arm.

4. The autoinjector of claim 2 , wherein the projection is configured to engage the interior surface of the outer sleeve.

5. The autoinjector of claim 2 , wherein the autoinjector is configured such that when the projection moves into the opening in the outer sleeve, the flexible arm moves into the relaxed position.

6. The autoinjector of claim 1 , comprising the medicament container containing the medicament, the medicament comprising a glucagon-like peptide-1 (GLP-1) or an analogue or derivative thereof.

7. The autoinjector of claim 1 , comprising a control spring coupled to the inner sleeve, and configured to transition from an energized state to an expanded state after the plunger moves into the drug delivery position.

8. The autoinjector of claim 7 , wherein the inner sleeve is configured to move axially relative to the outer sleeve under a biasing force of the control spring when the control spring transitions into the expanded state.

9. The autoinjector of claim 7 , comprising a drive spring having (i) a distal end in direct engagement with the plunger for biasing the plunger in a distal direction and (ii) a proximal end held in a fixed axial location as the plunger moves in the distal direction.

10. The autoinjector of claim 1 , wherein the autoinjector is configured such that when the flexible arm moves into the opening in the outer sleeve, the flexible arm moves into the relaxed position and the inner sleeve is configured to impact the outer sleeve to generate the audible signal or the tactile signal to indicate completion of dispensing of the medicament.

11. An autoinjector comprising:

a plunger movable along a longitudinal axis of the autoinjector between an initial position and a drug delivery position for delivering a medicament from a medicament container;

an inner sleeve configured to surround a proximal end of the plunger when the plunger is in the initial position, the inner sleeve comprising a tubular body and a flexible arm movable relative to the tubular body, the flexible arm comprising a first end coupled to the tubular body and a second end spaced from the tubular body, wherein the flexible arm is movable between an inwardly deflected position and a relaxed position; and

an outer sleeve comprising a sleeve body having a first end, a second end, and an interior surface defining a cylindrical cavity, the sleeve body comprising an opening radially extending through the sleeve body and longitudinally extending between the first end and the second end, wherein the opening is sized to receive a portion of the flexible arm,

wherein the autoinjector is configured such that after the plunger moves into the drug delivery position, the inner sleeve moves axially relative to the outer sleeve and into the cylindrical cavity of the outer sleeve, allowing the flexible arm to engage the interior surface of the outer sleeve and deflecting the flexible arm inwardly, and

wherein the autoinjector is configured such that an audible signal or a tactile signal is generated from an impact event between the inner sleeve and the outer sleeve to indicate completion of dispensing of the medicament.

12. The autoinjector of claim 11 , wherein the flexible arm comprises a projection extending radially outward relative to the longitudinal axis.

13. The autoinjector of claim 12 , wherein the opening in the outer sleeve is sized to receive the projection of the flexible arm.

14. The autoinjector of claim 12 , wherein the projection is configured to engage the interior surface of the outer sleeve.

15. The autoinjector of claim 12 , wherein the autoinjector is configured such that when the projection moves into the opening in the outer sleeve, the flexible arm moves into the relaxed position.

16. The autoinjector of claim 11 , comprising a control spring coupled to the inner sleeve, and configured to transition from an energized state to an expanded state after the plunger moves into the drug delivery position.

17. The autoinjector of claim 16 , wherein the inner sleeve is configured to move axially relative to the outer sleeve under a biasing force of the control spring when the control spring transitions into the expanded state.

18. The autoinjector of claim 16 , comprising a drive spring having (i) a distal end in direct engagement with the plunger for biasing the plunger in a distal direction and (ii) a proximal end held in a fixed axial location as the plunger moves in the distal direction.

19. The autoinjector of claim 11 , wherein the autoinjector is configured such that when the flexible arm moves into the opening in the outer sleeve, the flexible arm moves into the relaxed position and the inner sleeve is configured to impact the outer sleeve to generate the audible signal or the tactile signal to indicate completion of dispensing of the medicament.

20. A drug delivery device comprising:

a plunger movable along a longitudinal axis of the drug delivery device between an initial position and a drug delivery position for delivering a medicament from a medicament container;

an inner sleeve arranged around a proximal end of the plunger when the plunger is in the initial position, the inner sleeve comprising an inner sleeve body and a flexible arm extending from the inner sleeve body, wherein the flexible arm is movable relative to the inner sleeve body between an inwardly deflected position and a relaxed position; and

an outer sleeve comprising an outer sleeve body having an interior surface defining an interior space, the outer sleeve body comprising an opening radially extending through the outer sleeve body, wherein the opening is sized to receive a portion of the flexible arm,

wherein the drug delivery device is configured such that after the plunger moves into the drug delivery position, the inner sleeve moves axially relative to the outer sleeve and into the interior space of the outer sleeve, allowing the flexible arm to engage the interior surface of the outer sleeve and deflecting the flexible arm inwardly, and

wherein the drug delivery device is configured such that an audible signal or a tactile signal is generated from an impact event between the inner sleeve and the outer sleeve to indicate completion of dispensing of the medicament.

21. The drug delivery device of claim 20 , wherein the drug delivery device is configured such that when the flexible arm moves into the opening in the outer sleeve, the flexible arm moves into the relaxed position and the inner sleeve is configured to impact the outer sleeve to generate the audible signal or the tactile signal to indicate completion of dispensing of the medicament.

22. The drug delivery device of claim 20 , wherein the flexible arm comprises a first end coupled to the inner sleeve body and a second end spaced from the inner sleeve body.

23. The drug delivery device of claim 22 , wherein the flexible arm comprises a projection extending radially outward relative to the longitudinal axis.

24. The drug delivery device of claim 23 , wherein the projection is configured to engage the interior surface of the outer sleeve.

25. The drug delivery device of claim 23 , wherein the drug delivery device is configured such that when the projection moves into the opening in the outer sleeve, the flexible arm moves into the relaxed position.

26. The drug delivery device of claim 23 , comprising a spring coupled to the inner sleeve, and configured to transition from an energized state to an expanded state after the plunger moves into the drug delivery position.

27. The drug delivery device of claim 26 , wherein the inner sleeve is configured to move axially relative to the outer sleeve under a biasing force of the spring when the spring transitions into the expanded state.

28. The drug delivery device of claim 21 , wherein the outer sleeve body comprises a first end and a second end, and wherein the opening longitudinally extends between the first end and the second end of the outer sleeve body.

29. The drug delivery device of claim 21 , comprising the medicament container configured to hold the medicament, and a needle coupled to a distal end of the medicament container.

30. The drug delivery device of claim 21 , comprising the medicament container containing the medicament, the medicament comprising a glucagon-like peptide-1 (GLP-1) or an analogue or derivative thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2025
From: KEMP, THOMAS MARK; REVELLAT, HUGO
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 071235/0625 →
Priority Claims (1)
EP 15170590 · Jun 3, 2015 · regional
Continuity (4)
Continuation 18968712 · Dec 4, 2024
Continuation 17172602 · Feb 10, 2021
Continuation 15578668
Related Publication 20250161575A1 · May 22, 2025
References Cited (201)
US 4629454A · Grier · 1986 [cited by applicant]
US 4693711A · Bremer et al. · 1987 [cited by applicant]
US 4810249A · Haber et al. · 1989 [cited by applicant]
US 5114406A · Gabriel et al. · 1992 [cited by applicant]
US 5116313A · McGregor · 1992 [cited by applicant]
US 5127906A · Landry et al. · 1992 [cited by applicant]
US 5271527A · Haber et al. · 1993 [cited by applicant]
US 5391157A · Harris et al. · 1995 [cited by applicant]
US 7597685B2 · Olson · 2009 [cited by applicant]
US 7611495B1 · Gianturco · 2009 [cited by applicant]
US 7918824B2 · Bishop et al. · 2011 [cited by applicant]
US 8409138B2 · James et al. · 2013 [cited by applicant]
US 8734394B2 · Adams et al. · 2014 [cited by applicant]
US 8979807B2 · Grunhut et al. · 2015 [cited by applicant]
US 9044553B2 · James et al. · 2015 [cited by applicant]
US 9168339B2 · Cowe · 2015 [cited by applicant]
US 9199038B2 · Daniel · 2015 [cited by applicant]
US 9216251B2 · Daniel · 2015 [cited by applicant]
US 9216256B2 · Olson et al. · 2015 [cited by applicant]
US 9233213B2 · Olson et al. · 2016 [cited by applicant]
US 9402957B2 · Adams et al. · 2016 [cited by applicant]
US 9408976B2 · Olson et al. · 2016 [cited by applicant]
US 9744306B2 · Cowe · 2017 [cited by applicant]
US 9764096B2 · Maritan · 2017 [cited by applicant]
US 9872961B2 · Fourt et al. · 2018 [cited by applicant]
US 10118001B2 · Fourt et al. · 2018 [cited by applicant]
US 10314981B2 · Sampson et al. · 2019 [cited by applicant]
US 10350362B2 · Dennis, Jr. et al. · 2019 [cited by applicant]
US 10363377B2 · Atterbury et al. · 2019 [cited by applicant]
US 10420898B2 · Daniel · 2019 [cited by applicant]
US 10569019B2 · Hirschel et al. · 2020 [cited by applicant]
US 10799647B2 · Hostettler et al. · 2020 [cited by applicant]
US 10888668B2 · Mosebach et al. · 2021 [cited by applicant]
US 10918811B2 · Mosebach et al. · 2021 [cited by applicant]
US 10926032B2 · Mosebach et al. · 2021 [cited by applicant]
US 11298462B2 · Atterbury et al. · 2022 [cited by applicant]
US 11357922B2 · Mosebach et al. · 2022 [cited by applicant]
US 11383044B2 · Tschirren et al. · 2022 [cited by applicant]
US 11400232B2 · Schader et al. · 2022 [cited by applicant]
US 11452821B2 · LaFever et al. · 2022 [cited by applicant]
US 11654246B2 · Revellat et al. · 2023 [cited by applicant]
US 12102812B2 · Mosebach et al. · 2024 [cited by applicant]
US 12156994B2 · Mosebach et al. · 2024 [cited by applicant]
US 12179000B2 · Mosebach et al. · 2024 [cited by applicant]
US 20020188247A1 · Peery · 2002 [cited by applicant]
US 20040039336A1 · Amark et al. · 2004 [cited by applicant]
US 20040210199A1 · Atterbury et al. · 2004 [cited by applicant]
US 20050027255A1 · Lavi et al. · 2005 [cited by applicant]
US 20050038392A1 · DeSalvo · 2005 [cited by applicant]
US 20050101919A1 · Brunnberg · 2005 [cited by applicant]
US 20070088248A1 · Glenn et al. · 2007 [cited by applicant]
US 20080021373A1 · Rosati · 2008 [cited by applicant]
US 20080269692A1 · James et al. · 2008 [cited by applicant]
US 20100198182A1 · Lanigan et al. · 2010 [cited by applicant]
US 20110026721A1 · Parker · 2011 [cited by applicant]
US 20110054414A1 · Shang et al. · 2011 [cited by applicant]
US 20110105952A1 · Bernstein et al. · 2011 [cited by applicant]
US 20110238014A1 · Maritan · 2011 [cited by applicant]
US 20130023749A1 · Afanasewicz et al. · 2013 [cited by applicant]
US 20130090605A1 · O'Connor et al. · 2013 [cited by applicant]
US 20130131595A1 · Ekman et al. · 2013 [cited by applicant]
US 20130211330A1 · Pedersen et al. · 2013 [cited by applicant]
US 20130317427A1 · Brereton et al. · 2013 [cited by applicant]
US 20130324925A1 · Brereton · 2013 [cited by examiner]
US 20130324939A1 · Brereton et al. · 2013 [cited by applicant]
US 20130345642A1 · Cowe · 2013 [cited by applicant]
US 20140114250A1 · DeSalvo et al. · 2014 [cited by applicant]
US 20140243751A1 · Brereton et al. · 2014 [cited by applicant]
US 20140243757A1 · Dasbach et al. · 2014 [cited by applicant]
US 20140276568A1 · Worden et al. · 2014 [cited by applicant]
US 20140343527A1 · Scarpine et al. · 2014 [cited by applicant]
US 20150265772A1 · Maritan · 2015 [cited by applicant]
US 20150320939A1 · Beek et al. · 2015 [cited by applicant]
US 20160008541A1 · Hirschel et al. · 2016 [cited by applicant]
US 20160008542A1 · Hirschel et al. · 2016 [cited by applicant]
US 20160015899A1 · Plumptre et al. · 2016 [cited by applicant]
US 20160144133A1 · Kemp · 2016 [cited by applicant]
US 20160361503A1 · Bendek et al. · 2016 [cited by applicant]
US 20170136173A1 · Melander et al. · 2017 [cited by applicant]
US 20180064875A1 · Holmqvist · 2018 [cited by applicant]
US 20180154078A1 · Mosebach et al. · 2018 [cited by applicant]
US 20180154085A1 · Mosebach et al. · 2018 [cited by applicant]
US 20180154089A1 · Mosebach et al. · 2018 [cited by applicant]
US 20180169342A1 · Mosebach et al. · 2018 [cited by applicant]
US 20190374717A1 · Swanson et al. · 2019 [cited by applicant]
US 20200289764A1 · Revellat et al. · 2020 [cited by applicant]
US 20210093790A1 · Mosebach et al. · 2021 [cited by applicant]
US 20210128837A1 · Mosebach et al. · 2021 [cited by applicant]
US 20210170115A1 · Mosebach et al. · 2021 [cited by applicant]
US 20210369966A1 · Schader et al. · 2021 [cited by applicant]
US 20220257865A1 · Mosebach et al. · 2022 [cited by applicant]
US 20220305206A1 · Schader et al. · 2022 [cited by applicant]
US 20230277777A1 · Revellat et al. · 2023 [cited by applicant]
US 20240416051A1 · Mosebach et al. · 2024 [cited by applicant]
CN 200987443Y · 2007 [cited by applicant]
CN 101107032A · 2008 [cited by applicant]
CN 201111673Y · 2008 [cited by applicant]
CN 201243374Y · 2009 [cited by applicant]
CN 102209564A · 2011 [cited by applicant]
CN 102665801A · 2012 [cited by applicant]
CN 102842236A · 2012 [cited by applicant]
CN 202887394U · 2013 [cited by applicant]
CN 103177716A · 2013 [cited by applicant]
CN 103235538A · 2013 [cited by applicant]
CN 103974733A · 2014 [cited by applicant]
CN 104023769A · 2014 [cited by applicant]
CN 104080499A · 2014 [cited by applicant]
CN 104519929A · 2015 [cited by applicant]
CN 105188809A · 2015 [cited by applicant]
CN 105327432A · 2016 [cited by applicant]
CN 105451792A · 2016 [cited by applicant]
CN 106573114A · 2017 [cited by applicant]
DE 7833454U1 · 1979 [cited by applicant]
DE 3935672A1 · 1990 [cited by applicant]
EP 2583705A1 · 2013 [cited by applicant]
EP 2722065A1 · 2014 [cited by applicant]
EP 2727617A1 · 2014 [cited by applicant]
EP 2823841A1 · 2015 [cited by applicant]
EP 2868338A1 · 2015 [cited by applicant]
EP 3302632A1 · 2020 [cited by applicant]
JP H05508098A · 1993 [cited by applicant]
JP H06190041A · 1994 [cited by applicant]
JP H07509636A · 1995 [cited by applicant]
JP 2005508205A · 2005 [cited by applicant]
JP 2011519712A · 2011 [cited by applicant]
JP 2012504006A · 2012 [cited by applicant]
JP 2013526894A · 2013 [cited by applicant]
JP 2013526904A · 2013 [cited by applicant]
JP 2013146600A · 2013 [cited by applicant]
JP 2013534164A · 2013 [cited by applicant]
JP 2014526298A · 2014 [cited by applicant]
JP 2014531961A · 2014 [cited by applicant]
JP 2015526215A · 2015 [cited by applicant]
JP 2015536184A · 2015 [cited by applicant]
JP 2016512766A · 2016 [cited by applicant]
JP 2016513507A · 2016 [cited by applicant]
JP 2016526460A · 2016 [cited by applicant]
JP 2016534790A · 2016 [cited by applicant]
RU 2140794C1 · 1999 [cited by applicant]
RU 2012137269A · 2014 [cited by applicant]
WO WO1992017223A1 · 1992 [cited by applicant]
WO WO1994003222A2 · 1994 [cited by applicant]
WO WO2002047746A1 · 2002 [cited by applicant]
WO WO2002092153A2 · 2002 [cited by applicant]
WO WO2005046773A1 · 2005 [cited by applicant]
WO WO2006079481A1 · 2006 [cited by applicant]
WO WO2009140251A2 · 2009 [cited by applicant]
WO WO2010035057A1 · 2010 [cited by applicant]
WO WO2010136077A1 · 2010 [cited by applicant]
WO WO2011043714A1 · 2011 [cited by applicant]
WO WO2011079278A1 · 2011 [cited by applicant]
WO WO2011109205A2 · 2011 [cited by applicant]
WO WO2011123024A1 · 2011 [cited by applicant]
WO WO2012022810A2 · 2012 [cited by applicant]
WO WO2012045350A1 · 2012 [cited by examiner]
WO WO2013034984A2 · 2013 [cited by applicant]
WO WO2013034985A2 · 2013 [cited by applicant]
WO WO2013050474A1 · 2013 [cited by applicant]
WO WO2013057032A1 · 2013 [cited by applicant]
WO WO2013057033A1 · 2013 [cited by applicant]
WO WO2013057034A1 · 2013 [cited by applicant]
WO WO2014005808A1 · 2014 [cited by applicant]
WO WO2014033141A1 · 2014 [cited by applicant]
WO WO2014066461A1 · 2014 [cited by applicant]
WO WO2014139914A1 · 2014 [cited by applicant]
WO WO2014139922A1 · 2014 [cited by applicant]
WO WO2014146209A1 · 2014 [cited by applicant]
WO WO2014164943A1 · 2014 [cited by applicant]
WO WO2015004049A1 · 2015 [cited by applicant]
WO WO2015004050A1 · 2015 [cited by applicant]
WO WO2015019071A1 · 2015 [cited by applicant]
WO WO2015052224A1 · 2015 [cited by applicant]
WO WO2015062915A1 · 2015 [cited by applicant]
WO WO2015074976A1 · 2015 [cited by applicant]
WO WO2016001304A1 · 2016 [cited by applicant]
WO WO2016193343A1 · 2016 [cited by applicant]
WO WO2016193344A1 · 2016 [cited by applicant]
WO WO2016193346A1 · 2016 [cited by applicant]
WO WO2019074788A1 · 2019 [cited by applicant]
WO WO2020190529A1 · 2020 [cited by applicant]
U.S. Appl. No. 16/759,488, filed Apr. 27, 2020, Revellat et al. [cited by applicant]
U.S. Appl. No. 16/759,789, filed Apr. 28, 2020, Schader et al. [cited by applicant]
Engineers Edge, “Transducers USA Announced Improved TRIP60 Series of Audio Alerts,” Engineering and Technology News, Aug. 2007, 3 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2016/062455, mailed on Dec. 5, 2017, 7 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2016/062449, mailed on Dec. 14, 2017, 7 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2016/062450, mailed on Dec. 14, 2017, 9 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2016/062452, mailed on Dec. 14, 2017, 8 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2016/062454, mailed on Dec. 14, 2017, 8 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2018/079915, mailed on May 14, 2020, 9 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2018/079917, mailed on May 14, 2020, 9 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2016/062455, mailed on Sep. 27, 2016, 9 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2016/062449, mailed on Aug. 17, 2016, 8 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2016/062450, mailed on Aug. 5, 2016, 9 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2016/062452, mailed on Sep. 15, 2016, 11 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2016/062454, mailed on Aug. 5, 2016, 9 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2018/079915, mailed on Dec. 5, 2018, 10 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2018/079917, mailed on Dec. 5, 2018, 10 pages. [cited by applicant]
Karpova, “The basics of surdopedagogy,” Ekaterinburg, pp. 20-21, 2008, 7 pages (with machine translation). [cited by applicant]
National Standards of People's Republic of China, “Audible and/or Visual Fire Alarm Signaling Appliances”, General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China, Jul.… [cited by applicant]
National Standards of People's Republic of China, “Fire Detection and Alarm Systems-Smoke Alarms”, General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China, Jul. 2006, 4… [cited by applicant]
National Standards of People's Republic of China, “Vehicle Electronic Sirens”, General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China, Dec. 2014, 31 pages (with machin… [cited by applicant]